| Ramakrishnan P Unni, MD | |
|
400 West 84th Dr., Merrillville, IN 46410 | |
| (219) 769-8641 | |
| (219) 769-2280 |
| Full Name | Ramakrishnan P Unni |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 400 West 84th Dr., Merrillville, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063493542 | NPI | - | NPPES |
| 0091108094 | Other | IL | BLUE SHIELD OF ILLINOIS |
| 100158110A | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 01026587A (Indiana) | Primary |
| Entity Name | Uro Surgery Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477648566 PECOS PAC ID: 8628975562 Enrollment ID: O20031217000998 |
News Archive
Cancer Research UK scientists have revealed how a combination of two very different drugs - currently being tested in clinical trials - amplifies the destruction of pancreatic cancer cells, according to research published in the Journal of Experimental Medicine, today.
Many people can drop pounds quickly in the early phases of a diet, but studies have found that it is difficult to keep the weight off in the long term. For post-menopausal women, natural declines in energy expenditure could make long-term weight loss even more challenging. A new study finds that in post-menopausal women, some behaviors that are related to weight loss in the short term are not effective or sustainable for the long term. Interventions targeting these behaviors could improve long-term obesity treatment outcomes.
PCI Biotech Holding ASA, the Norwegian drug delivery company focusing on effective delivery of cancer therapeutics, today announced that the first patient has received treatment in the Phase I/II trial with the lead candidate Amphinex(R), which uses a new approach called photochemical internalisation.
Sildenafil, a drug used to treat erectile dysfunction and pulmonary hypertension, has another possible use—helping children and young adults with congenital heart disease to better tolerate exercise.
As the COVID-19 pandemic continues to cause an immense impact across many parts of the world, the role played by immune responses is becoming more evident every day. A recent funded paper published on the preprint server medRxiv* in September 2020 reports the initiation of a Phase I trial of a drug that increases antibody and cell-mediated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ramakrishnan P Unni, MD 400 West 84th Dr., Merrillville, IN 46410 Ph: (219) 769-8641 | Ramakrishnan P Unni, MD 400 West 84th Dr., Merrillville, IN 46410 Ph: (219) 769-8641 |
News Archive
Cancer Research UK scientists have revealed how a combination of two very different drugs - currently being tested in clinical trials - amplifies the destruction of pancreatic cancer cells, according to research published in the Journal of Experimental Medicine, today.
Many people can drop pounds quickly in the early phases of a diet, but studies have found that it is difficult to keep the weight off in the long term. For post-menopausal women, natural declines in energy expenditure could make long-term weight loss even more challenging. A new study finds that in post-menopausal women, some behaviors that are related to weight loss in the short term are not effective or sustainable for the long term. Interventions targeting these behaviors could improve long-term obesity treatment outcomes.
PCI Biotech Holding ASA, the Norwegian drug delivery company focusing on effective delivery of cancer therapeutics, today announced that the first patient has received treatment in the Phase I/II trial with the lead candidate Amphinex(R), which uses a new approach called photochemical internalisation.
Sildenafil, a drug used to treat erectile dysfunction and pulmonary hypertension, has another possible use—helping children and young adults with congenital heart disease to better tolerate exercise.
As the COVID-19 pandemic continues to cause an immense impact across many parts of the world, the role played by immune responses is becoming more evident every day. A recent funded paper published on the preprint server medRxiv* in September 2020 reports the initiation of a Phase I trial of a drug that increases antibody and cell-mediated immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
› Verified 9 days ago
Bassem Atassi, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 206 E 86th Pl, Merrillville, IN 46410 Phone: 219-738-2722 Fax: 219-736-7820 | |
Brian Robert Billmeyer, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 400 W 84th Dr, Merrillville, IN 46410 Phone: 219-736-1255 Fax: 219-738-1276 | |
Dr. Ramesh Unni, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 400 West 84th Drive, Merrillville, IN 46410 Phone: 219-769-8641 Fax: 219-769-2280 | |
Nishendu Baxi, MD Urology Medicare: Medicare Enrolled Practice Location: 400 W 84th Dr, Merrillville, IN 46410 Phone: 219-736-1255 Fax: 219-738-1276 | |
Bruce R Yalowitz, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 400 W 84th Dr, Merrillville, IN 46410 Phone: 219-736-1255 Fax: 219-738-1276 | |
Dr. Manoj V Rao, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 400 W 84th Dr, Merrillville, IN 46410 Phone: 219-736-1255 |